What proportion of alcohol and drug treatment episodes in Australia are amphetamine-related?

In 2017-18, amphetamineswere the principal drug of concern in 27% of all alcohol and other drug treatment episodes in Australia.

In Australia in 2017-18, alcohol accounted for 35% of all alcohol and other drug treatment episodes; heroin accounted for 6%; cannabis accounted for 22%; amphetamines accounted for 27%; and other drugs accounted for 11%.

Source: Australian Institute of Health and Welfare (AIHW). Alcohol and Other Drug Treatment Services in Australia 2017-18.

Please note: Percentages may not tally to 100% due to rounding.

† Amphetamines are Central Nervous System (CNS) stimulants that increase neurotransmitter activity. Methamphetamine is a more potent form of amphetamine. The National Minimum Data Set does not provide data on methamphetamine use alone. Instead, treatment episodes due to methamphetamine use are subsumed within ‘amphetamines’. This category includes amphetamine, dexamphetamine, methamphetamine, amphetamine analogues, and amphetamines not elsewhere classified.

Principal Drug of Concern: The main substance that leads an individual to seek treatment from an alcohol and drug treatment agency (as stated by the individual).

Treatment Episode: A period of contact between a client and a treatment provider. Only ‘closed’ treatment episodes are included in the data used here. An episode is closed if there is a change in the principal drug of concern, main treatment, or service delivery setting; if the treatment ends; or if the patient is imprisoned or dies.